Multiple apoptosis- and inflammation-related proteins

The term Multiple apoptosis- and inflammation-related proteins refers to a broad and heterogeneous group of molecular entities rather than a single therapeutic target. This category typically encompasses various proteins involved in programmed cell death pathways, such as caspases and Bcl-2 family members, as well as mediators of the inflammatory response, including cytokines like TNF-alpha and IL-6, and transcription factors like NF-kappaB. These proteins play critical roles in maintaining cellular homeostasis and responding to injury or infection. Dysregulation of these pathways is a hallmark of numerous pathologies, including cancer, chronic inflammatory disorders, and neurodegenerative diseases. Because this is a collective designation, drugs interacting with these proteins have diverse mechanisms of action, ranging from direct enzymatic inhibition to receptor antagonism.

Varies depending on the specific protein within the group (e.g., caspase inhibition, cytokine neutralization, or NF-kappaB modulation).